These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
434 related articles for article (PubMed ID: 22209870)
21. A potential role for estrogen in experimental autoimmune encephalomyelitis and multiple sclerosis. Offner H; Polanczyk M Ann N Y Acad Sci; 2006 Nov; 1089():343-72. PubMed ID: 17261780 [TBL] [Abstract][Full Text] [Related]
22. Estrogens as potential therapeutic agents in multiple sclerosis. Niino M; Hirotani M; Fukazawa T; Kikuchi S; Sasaki H Cent Nerv Syst Agents Med Chem; 2009 Jun; 9(2):87-94. PubMed ID: 20021342 [TBL] [Abstract][Full Text] [Related]
23. Lentivirus-mediated estrogen receptor α overexpression in the central nervous system ameliorates experimental autoimmune encephalomyelitis in mice. Hu X; Qin X Int J Mol Med; 2013 May; 31(5):1209-21. PubMed ID: 23525227 [TBL] [Abstract][Full Text] [Related]
24. Pregnancy level of estrogen attenuates experimental autoimmune encephalomyelitis in both ovariectomized and pregnant C57BL/6 mice through expansion of Treg and Th2 cells. Haghmorad D; Amini AA; Mahmoudi MB; Rastin M; Hosseini M; Mahmoudi M J Neuroimmunol; 2014 Dec; 277(1-2):85-95. PubMed ID: 25457839 [TBL] [Abstract][Full Text] [Related]
25. Steroid protection in the experimental autoimmune encephalomyelitis model of multiple sclerosis. Garay L; Gonzalez Deniselle MC; Gierman L; Meyer M; Lima A; Roig P; De Nicola AF Neuroimmunomodulation; 2008; 15(1):76-83. PubMed ID: 18667803 [TBL] [Abstract][Full Text] [Related]
26. Impact of sex steroids on neuroinflammatory processes and experimental multiple sclerosis. Kipp M; Beyer C Front Neuroendocrinol; 2009 Jul; 30(2):188-200. PubMed ID: 19393685 [TBL] [Abstract][Full Text] [Related]
33. Estrogen inhibits estrogen receptor α-mediated rho-kinase expression in experimental autoimmune encephalomyelitis rats. Feng J; Zhang G; Hu X; Si Chen C; Qin X Synapse; 2013 Jul; 67(7):399-406. PubMed ID: 23401288 [TBL] [Abstract][Full Text] [Related]
34. Estrogen receptors and gonadal steroids in vulnerability and protection of dopamine neurons in a mouse model of Parkinson's disease. Al-Sweidi S; Morissette M; Bourque M; Di Paolo T Neuropharmacology; 2011 Sep; 61(4):583-91. PubMed ID: 21586296 [TBL] [Abstract][Full Text] [Related]
35. Neuroprotective and neurotoxic outcomes of androgens and estrogens in an oxidative stress environment. Duong P; Tenkorang MAA; Trieu J; McCuiston C; Rybalchenko N; Cunningham RL Biol Sex Differ; 2020 Mar; 11(1):12. PubMed ID: 32223745 [TBL] [Abstract][Full Text] [Related]
36. The loss of estrogen efficacy against cerebral ischemia in aged postmenopausal female mice. Cai M; Ma YL; Qin P; Li Y; Zhang LX; Nie H; Peng Z; Dong H; Dong HL; Hou WG; Xiong LZ Neurosci Lett; 2014 Jan; 558():115-9. PubMed ID: 24246902 [TBL] [Abstract][Full Text] [Related]
37. Beneficial role of the GPR30 agonist G-1 in an animal model of multiple sclerosis. Blasko E; Haskell CA; Leung S; Gualtieri G; Halks-Miller M; Mahmoudi M; Dennis MK; Prossnitz ER; Karpus WJ; Horuk R J Neuroimmunol; 2009 Sep; 214(1-2):67-77. PubMed ID: 19664827 [TBL] [Abstract][Full Text] [Related]
38. Estrogen and SERM neuroprotection in animal models of Parkinson's disease. Morissette M; Al Sweidi S; Callier S; Di Paolo T Mol Cell Endocrinol; 2008 Aug; 290(1-2):60-9. PubMed ID: 18515001 [TBL] [Abstract][Full Text] [Related]
39. Statins and demyelination. Weber MS; Zamvil SS Curr Top Microbiol Immunol; 2008; 318():313-24. PubMed ID: 18219823 [TBL] [Abstract][Full Text] [Related]
40. Neuroprotection and neurogeneration in MS and its animal model EAE effected by glatiramer acetate. Arnon R; Aharoni R J Neural Transm (Vienna); 2009 Nov; 116(11):1443-9. PubMed ID: 19669693 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]